Artificial Sweetener May Make Immunotherapy Less Effective in Cancer Patients
New research conducted in mice and humans finds the artificial sweetener sucralose changes gut bacteria in ways that can limit immunotherapy response in cancer patients.
Health News is provided as a service to C&C Drugs site users by HealthDay. C&C Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.